当前位置: X-MOL首页全球导师 国内导师 › 邵建永

个人简介

学习教育经历 2000.7-2012.4:瑞典Karolinska Institutet在职学习,获哲学博士学位。 2000.7-2002.12:中山大学肿瘤防治中心肿瘤学博士研究生学习,获医学博士学位。 1999.10-2000.11月:获世界卫生组织(WHO)IARC奖学金,赴瑞典卡罗林斯卡医学院(Karolinska Institute)进修肿瘤分子生物学研究 1997.1-1997.7:香港中文大学医学院病理系进修分子病理学 1989.9-1992.7:中山医科大学病理教研室研究生学习,获医学硕士学位 1984.9-1989.7:安徽省蚌埠医学院临床医疗系学习,获医学学士学位 工作任职经历 2014.05-现在: 中山大学肿瘤防治中心兼任防癌体检中心主任 2011.03-现在: 中山大学肿瘤防治中心分子诊断科主任 2007.2-2010.12:中山大学肿瘤防治中心中共纪律检查委员会委员 2004.12-现在:中山大学肿瘤防治中心教授,主任医师,博士生导师 2006.8-2010.12:中山大学肿瘤防治中心病理科副主任,分子病理实验室主任 2000.12-2004.11:中山大学肿瘤防治中心副教授 1995.8-2000.11:中山医科大学肿瘤医院主治医师 1992.7-2005.7:中山医科大学肿瘤医院住院医师

研究领域

主要从事肿瘤临床病理诊断工作,精于各种常见肿瘤和大部分疑难病理的临床病理诊断和鉴别诊断工作

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1.Chen KL, Chen J, Rao HL, Guo Y, Huang HQ, Zhang L,Shao JY, Lin TY, Jiang WQ, Zou DH, Hu LY, Wirian ML, Cai QQ. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chin J Cancer. 2015 May 28;34(1):18. doi: 10.1186/s40880-015-0015-9. 2.Xu YF, Ren XY, Li YQ, He QM, Tang XR, Sun Y,Shao JY, Jia WH, Kang TB, Zeng MS, Liu N, Ma J. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma. BMC Cancer. 2015 Apr 30;15(1):332. doi: 10.1186/s12885-015-1351-5. 3.Fu S, Liang Y, Lin YB, Wang F, Huang MY, Zhang ZC, Wang J, Cen WJ, Shao JY*. The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients. PLoS One. 2015 Apr 23;10(4):e0124354. doi: 10.1371/journal.pone.0124354. eCollection 2015. 4.Fu S, Wang F, Shao Q, Zhang X, Duan LP, Zhang X, Zhang L, Shao JY*.Detection of EML4-ALK fusion gene in Chinese non-small cell lung cancer by using a sensitive quantitative real-time reverse transcriptase PCR technique. Appl Immunohistochem Mol Morphol. 2015 Apr;23(4):245-54. doi: 10.1097/PDM.0000000000000038. 5.Wen Y, Cai L, Zhang X, Zhu J, Zhang Z, Shao J, Zhang L. Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma. Medicine (Baltimore). 2014 Dec;93(29):e296. doi: 10.1097/MD.0000000000000296. 6.Tao CJ, Lin L, Zhou GQ, Tang LL, Chen L, Mao YP, Zeng MS, Kang TB, Jia WH, Shao JY, Mai HQ, Lin AH, Ma J, Sun Y. Comparison of Long-Term Survival and Toxicity of Cisplatin Delivered Weekly versus Every Three Weeks Concurrently with Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma. PLoS One.2014 Oct 16;9(10):e110765. doi: 10.1371/journal.pone.0110765. eCollection 2014. 7.Liu N, He QM, Chen JW, Li YQ, Xu YF, Ren XY, Sun Y, Mai HQ, Shao JY, Jia WH, Kang TB, Zeng MS, Ma J. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth. Mol. Cancer. 2014 May 19;13(1):111. doi: 10.1186/1476-4598-13-111. 8.Wang HY, Li YY, Fu S, Wang XP, Huang MY, Zhang X, Shao Q, Deng L, Zeng MS, Zeng YX, Shao JY*. MicroRNA-30a promotes invasiveness and metastasis in vitro and in vivo through epithelial-mesenchymal transition and results in poor survival of nasopharyngeal carcinoma patients. Exp. Biol. Med (Maywood). 2014 May 8. [Epub ahead of print] 9.Mao YP, Zhou GQ, Liu LZ, Guo R, Sun Y, Li L, Lin AH, Zeng MS, Kang TB, Jia WH, Shao JY, Mai HQ, Ma J. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy. Br. J. Cancer. 2014 May 27;110(11):2633-9. doi: 10.1038/bjc.2014.243. 10.Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC, Ye W, Zeng YX, Shao JY*. Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing. Clin Chem. 2014 Feb 21. [Epub ahead of print] 11.Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, Zeng YX, Shao JY*. Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma. PLoS One. 2014 Jan 21;9(1):e86149. doi: 10.1371/journal.pone.0086149. 12.Fu S, Wang F, Shao Q, Zhang X, Duan LP, Zhang X, Zhang L, Shao JY. Detection of EML4-ALK Fusion Gene in Chinese Non-Small Cell Lung Cancer by Using a Sensitive Quantitative Real-Time Reverse Transcriptase PCR Technique. Diagn Mol Pathol. 2014 Jan 30. [Epub ahead of print] 13.Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY*. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. World J Gastroenterol. 2014,7;20(1):183-92 14.Zhang ZC1, Fu S1, Wang F1, Wang HY1, Zeng YX2, Shao JY1. Oncogene mutational profile in nasopharyngeal carcinoma. Onco Targets Ther. 2014 Mar 20;7:457-67(IF=1.342) 15.Li YY, Fu S, Wang XP, Wang HY, Zeng MS, Shao JY* Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients. PLoS One. 2013 Aug 14;8(8):e71764. doi: 10.1371/journal.pone.0071764. 16.Zhao ZR, Wang JF, Lin YB, Wang F, Fu S, Zhang SL, Su XD, Jiang L, Zhang YG, Shao JY* Long H* Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance. Med Oncol. 2014 Jan;31(1):810. doi: 10.1007/s12032-013-0810-6. 17.Wang F, Fu S, Shao Q, Zhou YB, Zhang X, Zhang X, Xue C, Lin JG, Huang LX, Zhang L, Zhang WM, and Shao JY*. High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR. J Transl Med. 2013; 11: 90. 18.Zhang JX, Cai MB, Wang XP, Duan LP, Shao Q, Tong ZT, Liao DZ, Li YY, Huang MY, Zeng YX, Shao JY*. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma. Med Oncol. 2013 Mar;30(1):390. 19.Hu C, Wei W, Chen X, Woodman CB, Yao Y, Nicholls JM, Joab I, Sihota SK, Shao JY, Derkaoui KD, Amari A, Maloney SL, Bell AI, Murray PG, Dawson CW, Young LS, Arrand JR. A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PLoS One. 2012;7(7):e41055. 20.Cai MB, Han HQ, Bei JX, Liu CC, Lei JJ, Cui Q, Feng QS, Wang HY, Zhang JX, Liang Y, Chen LZ, Kang TB, Shao JY, Zeng YX. Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma. Int J Biol Sci. 2012;8(6):891-900.

推荐链接
down
wechat
bug